RenovaCare, Inc. RCAR
0.00 USD 0.00 (+0.00%)
At closeNov 2, 2026, 4:00 PM EST
0.0002 Day range 0.0002
0.0001 52-week range 0.0002
- YTD
- 0.00%
- 1 year
- 0.00%
- Market cap
- 8.73K
- EPS (ttm)
- -0.06
- YTD return
- 0.00%
- 1-year return
- 0.00%
- Volume
- 3.33K
- Avg volume
- 27
- Open
- 0.0002
- Previous close
- 0.0001
- Day's range
- 0.0002 – 0.0002
- 52-week range
- 0.0001 – 0.0002
YTD 0.0000 (0.00%)
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 18, 2022 | Sep 1, 2022 | 0.00 | 0.00 | — | — |
| Aug 12, 2022 | Jun 1, 2022 | 0.00 | -0.03 | — | — |
| May 12, 2022 | Mar 1, 2022 | 0.00 | -0.02 | — | — |
| Mar 30, 2022 | Dec 1, 2021 | 0.00 | -0.01 | — | — |
| Nov 12, 2021 | Sep 1, 2021 | 0.00 | -0.02 | — | — |
| Aug 3, 2021 | Jun 1, 2021 | 0.00 | -0.01 | — | — |
News
Contrasting Biofrontera (NASDAQ:BFRI) & RenovaCare (OTCMKTS:RCAR) 
RenovaCare Inc. Provides Notice of Proposed Derivative Settlement to All Record Holders and Beneficial Owners of RenovaCare, Inc. 
Hagens Berman Sobol Shapiro LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of RenovaCare Securities - RCAR 
RenovaCare Announces Termination of StemCell Systems R&D Agreement 
SHAREHOLDER ALERT: Rigrodsky Law, P.A. is Investigating RenovaCare, Inc. 
RenovaCare Announces Management Changes 
RenovaCare Provides Clinical and Corporate Update 
RM LAW Announces Investigation of RenovaCare, Inc. 
SHAREHOLDER ALERT: Robbins LLP Investigates RenovaCare, Inc. (RCAR) on Behalf of Investors 
RENOVACARE ALERT: Bragar Eagel & Squire, P.C. is Investigating RenovaCare, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Your note
Sign in to keep a note on RCAR — it syncs with the Stock Master app.